Rocket Pharmaceuticals (RCKT) News Today $10.47 -0.40 (-3.68%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$10.76 +0.29 (+2.81%) As of 02/21/2025 07:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Brokerages Set Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Price Target at $47.27February 20 at 2:05 AM | americanbankingnews.comRocket Pharmaceuticals (RCKT) Projected to Post Earnings on MondayRocket Pharmaceuticals (NASDAQ:RCKT) will be releasing earnings before the market opens on Monday, February 24, Financial Modeling Prep reports.February 17, 2025 | marketbeat.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Consensus Recommendation of "Moderate Buy" from AnalystsShares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Get Free Report) have earned a consensus rating of "Moderate Buy" from the twelve ratings firms that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a hold recommendation and eleven have issued a buyFebruary 17, 2025 | marketbeat.comRocket Pharma Is A Buy At These Prices With Promising DataFebruary 12, 2025 | seekingalpha.comPokemon TCG's Destined Rivals Set Brings Team Rocket Back In MayFebruary 11, 2025 | msn.comSovran Advisors LLC Takes Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Sovran Advisors LLC bought a new position in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 150,767 shares of the biotechnologyFebruary 11, 2025 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Sets New 1-Year Low - Time to Sell?Rocket Pharmaceuticals (NASDAQ:RCKT) Reaches New 1-Year Low - Should You Sell?February 10, 2025 | marketbeat.comJennison Associates LLC Acquires 29,564 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Jennison Associates LLC raised its holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 72.6% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 70,304 shares of the biotechnology company's stock after acquiriFebruary 7, 2025 | marketbeat.comSG Americas Securities LLC Acquires 48,793 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)SG Americas Securities LLC lifted its holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 796.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 54,921 shares of the biotechnology company's stockJanuary 31, 2025 | marketbeat.comRocket Lab: With A Rosy Outlook Ahead, I'm Waiting For A Discount To BuyJanuary 27, 2025 | seekingalpha.comRocket Pharmaceuticals vice president sells $9,300 in stockJanuary 27, 2025 | msn.comFY2024 Earnings Estimate for RCKT Issued By Leerink PartnrsRocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) - Research analysts at Leerink Partnrs increased their FY2024 earnings per share estimates for shares of Rocket Pharmaceuticals in a report released on Wednesday, January 22nd. Leerink Partnrs analyst M. Foroohar now anticipates that the biJanuary 24, 2025 | marketbeat.comCantor Fitzgerald Forecasts RCKT FY2025 EarningsRocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) - Research analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for shares of Rocket Pharmaceuticals in a research note issued to investors on Tuesday, January 21st. Cantor Fitzgerald analyst J. Schimmer forecastsJanuary 23, 2025 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Sets New 52-Week Low - Should You Sell?Rocket Pharmaceuticals (NASDAQ:RCKT) Reaches New 12-Month Low - What's Next?January 23, 2025 | marketbeat.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Average Rating of "Moderate Buy" by AnalystsShares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Get Free Report) have been assigned an average rating of "Moderate Buy" from the twelve ratings firms that are currently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation anJanuary 23, 2025 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Shares Down 4% - Here's What HappenedRocket Pharmaceuticals (NASDAQ:RCKT) Trading Down 4% - Here's What HappenedJanuary 16, 2025 | marketbeat.comMirador Capital Partners LP Buys 67,755 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Mirador Capital Partners LP grew its holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 403.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 84,529 shares of the biotechnology company's stock after purchasing an addiJanuary 16, 2025 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Hits New 12-Month Low - Here's What HappenedRocket Pharmaceuticals (NASDAQ:RCKT) Reaches New 12-Month Low - Time to Sell?January 10, 2025 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Shares Up 6.9% - Time to Buy?Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Up 6.9% - Time to Buy?January 7, 2025 | marketbeat.comBuy Recommendation for Rocket Pharmaceuticals: Promising Potential of RP-L301 in Severe PKD CasesJanuary 7, 2025 | markets.businessinsider.comRocket Pharmaceuticals (RCKT) Gets a Buy from Bank of America SecuritiesJanuary 6, 2025 | markets.businessinsider.comRocket Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 2, 2025 | finance.yahoo.comRocket Pharmaceuticals Inc RCKTJanuary 1, 2025 | morningstar.comBrokers Set Expectations for RCKT Q4 EarningsRocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) - Analysts at Wedbush issued their Q4 2024 EPS estimates for shares of Rocket Pharmaceuticals in a research report issued to clients and investors on Monday, December 30th. Wedbush analyst Y. Zhong forecasts that the biotechnology company wJanuary 1, 2025 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Shares Up 3.7% - What's Next?Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Up 3.7% - Should You Buy?December 31, 2024 | marketbeat.comPromising Pipeline and Strategic Developments Propel Rocket Pharmaceuticals to ‘Buy’ RatingDecember 31, 2024 | markets.businessinsider.comRocket Pharmaceuticals (NASDAQ:RCKT) Now Covered by WedbushWedbush initiated coverage on shares of Rocket Pharmaceuticals in a report on Monday. They set an "outperform" rating and a $32.00 price objective for the company.December 30, 2024 | marketbeat.comRocket Pharmaceuticals, Inc. (RCKT): Is This Gene Therapy Stock a Good Buy Right Now?December 29, 2024 | msn.comRocket Pharmaceuticals, Inc. (RCKT): Is This Gene Therapy Stock a Good Buy Right Now?December 29, 2024 | insidermonkey.comSpotlight on Rocket Lab USA: Analyzing the Surge in Options ActivityDecember 26, 2024 | benzinga.comFederal watchdog sues Rocket Companies' subsidiary for alleged kickbacksDecember 23, 2024 | msn.comEvercore ISI Reaffirms Their Buy Rating on Rocket Pharmaceuticals (RCKT)December 23, 2024 | markets.businessinsider.comRocket Pharmaceuticals' SWOT analysis: gene therapy stock poised for growthDecember 23, 2024 | uk.investing.comRocket Pharmaceuticals (NASDAQ:RCKT) Reaches New 1-Year Low - What's Next?Rocket Pharmaceuticals (NASDAQ:RCKT) Hits New 1-Year Low - Time to Sell?December 19, 2024 | marketbeat.comFranklin Resources Inc. Reduces Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Franklin Resources Inc. decreased its position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 7.7% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 1,730,344 shares of the biotechnology company's stock after selling 143,345 shares during tDecember 19, 2024 | marketbeat.comState Street Corp Buys 322,156 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)State Street Corp lifted its stake in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 11.6% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,102,022 shares of the biotechnology company's stock after pDecember 19, 2024 | marketbeat.comJefferies Initiates Coverage of Rocket Pharmaceuticals (RCKT) with Buy RecommendationDecember 18, 2024 | msn.comRocket Pharmaceuticals Stock Soars as Jefferies Initiates Coverage at 'Buy'December 18, 2024 | investopedia.comRocket Pharmaceuticals (NASDAQ:RCKT) Shares Gap Up - What's Next?Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Gap Up - Still a Buy?December 18, 2024 | marketbeat.comJefferies Financial Group Initiates Coverage on Rocket Pharmaceuticals (NASDAQ:RCKT)Jefferies Financial Group started coverage on shares of Rocket Pharmaceuticals in a report on Wednesday. They set a "buy" rating and a $29.00 price objective for the company.December 18, 2024 | marketbeat.comSynovus Financial Corp Trims Stock Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Synovus Financial Corp reduced its holdings in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 43.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 95,504 shares of the biotechnolDecember 16, 2024 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Sets New 12-Month Low - Here's WhyRocket Pharmaceuticals (NASDAQ:RCKT) Hits New 52-Week Low - Time to Sell?December 13, 2024 | marketbeat.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Sold by Fmr LLCFmr LLC lessened its holdings in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 19.6% in the third quarter, according to its most recent filing with the SEC. The firm owned 465,456 shares of the biotechnology company's stock after selling 113,823 shares during the quarter. FmDecember 12, 2024 | marketbeat.comRocket Pharmaceuticals 13.2M share Spot Secondary priced at $12.50December 11, 2024 | markets.businessinsider.comPoint72 Asset Management L.P. Invests $888,000 in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Point72 Asset Management L.P. purchased a new stake in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 48,096 shares of the biotechnology company's stDecember 11, 2024 | marketbeat.comFrazier Life Sciences Management L.P. Lowers Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Frazier Life Sciences Management L.P. cut its position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 4.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,485,630 sharDecember 10, 2024 | marketbeat.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Purchased by Wellington Management Group LLPWellington Management Group LLP raised its holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 22.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,242,December 9, 2024 | marketbeat.comJanus Henderson Group PLC Has $35.06 Million Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Janus Henderson Group PLC decreased its position in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 35.0% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,897,340 shares of the biotechnology company'sDecember 7, 2024 | marketbeat.comErste Asset Management GmbH Purchases New Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Erste Asset Management GmbH purchased a new stake in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 44,700 shares of the biotechnology company's stock, valued at approximaDecember 4, 2024 | marketbeat.comWalleye Capital LLC Acquires Shares of 138,403 Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Walleye Capital LLC acquired a new position in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) in the 3rd quarter, according to its most recent disclosure with the SEC. The fund acquired 138,403 shares of the biotechnology company's stock, valued at approximately $2,556,000. WallDecember 4, 2024 | marketbeat.com Get Rocket Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RCKT and its competitors with MarketBeat's FREE daily newsletter. Email Address RCKT Media Mentions By Week RCKT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RCKT News Sentiment▼0.450.60▲Average Medical News Sentiment RCKT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RCKT Articles This Week▼36▲RCKT Articles Average Week Get Rocket Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RCKT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ADMA News Today ACLX News Today AKRO News Today RYTM News Today SRRK News Today IMVT News Today APLS News Today VKTX News Today ACAD News Today CRNX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RCKT) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredShocking Elon Move: Bigger than DOGE?After saving free speech with his acquisition of Twitter… And after blowing everyone’s minds with his recen...Brownstone Research | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RCKT Stock Alerts